SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
81 hedge funds and large institutions have $291M invested in scPharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
24% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 17
11.03% more ownership
Funds ownership: 68.75% → 79.78% (+11%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
81
Holding in Top 10
3
Calls
$1.84M
Puts
$1.28M
Top Buyers
| 1 | +$16.5M | |
| 2 | +$9.82M | |
| 3 | +$8.73M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$8.27M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$6.67M |
Top Sellers
| 1 | -$9.88M | |
| 2 | -$4.94M | |
| 3 | -$4.46M | |
| 4 |
Two Sigma Investments
New York
|
-$2.02M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.44M |